K-V Pharmaceutical Co

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$32.7M

392 transactions

Summary

K-V Pharmaceutical Co is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $13.5MSales: $14.8M43 insiders

Date	Insider	Type	Value
2013-09-26	Joint reporting: MULE EDWARD A; Silver Point Capital L.P.; O'Shea Robert J	Sell	$8.0M
2013-09-23	Joint reporting: MULE EDWARD A; Silver Point Capital L.P.; O'Shea Robert J	Buy	$6.0M
2013-11-13	Joint reporting: MULE EDWARD A; Silver Point Capital L.P.; O'Shea Robert J	Buy	$2.4M
2013-11-14	Joint reporting: MULE EDWARD A; Silver Point Capital L.P.; O'Shea Robert J	Buy	$2.2M
2013-11-18	Joint reporting: MULE EDWARD A; Silver Point Capital L.P.; O'Shea Robert J	Buy	$1.2M
2013-10-30	Vergis Janet S.	A	$0
2013-10-30	Vergis Janet S.	A	$0
2013-10-30	Vergis Janet S.	A	$0
2013-10-10	Norden Gregory	A	$0
2013-10-10	Norden Gregory	A	$0
2013-10-10	Norden Gregory	A	$0
2013-10-10	Goldfarb James M.	A	$0
2013-10-10	Goldfarb James M.	A	$0
2013-10-10	Goldfarb James M.	A	$0
2013-09-27	MAHADY JOSEPH M	A	$0
2013-09-27	MAHADY JOSEPH M	A	$0
2013-09-27	MAHADY JOSEPH M	A	$0
2013-09-27	MCHUGH THOMAS S(Chief Financial Officer)	A	$0
2013-09-27	DIVIS GREG J(CEO and President)	A	$0
2013-09-27	Christmas Patrick J.(General Counsel)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

K-V Pharmaceutical Co — Contributions, Lobbying & Contracts | Poliscope